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Abstract
Background: Rhipicephalus appendiculatus is the primary vector of Theileria parva, the etiological agent of East
Coast fever (ECF), a devastating disease of cattle in sub-Saharan Africa. We hypothesized that a vaccine targeting
tick proteins that are involved in attachment and feeding might affect feeding success and possibly reduce tick-
borne transmission of T. parva. Here we report the evaluation of a multivalent vaccine cocktail of tick antigens for
their ability to reduce R. appendiculatus feeding success and possibly reduce tick-transmission of T. parva in a
natural host-tick-parasite challenge model.
Methods: Cattle were inoculated with a multivalent antigen cocktail containing recombinant tick protective
antigen subolesin as well as two additional R. appendiculatus saliva antigens: the cement protein TRP64, and three
different histamine binding proteins. The cocktail also contained the T. parva sporozoite antigen p67C. The effect of
vaccination on the feeding success of nymphal and adult R. appendiculatus ticks was evaluated together with the
effect on transmission of T. parva using a tick challenge model.
Results: To our knowledge, this is the first evaluation of the anti-tick effects of these antigens in the natural host-
tick-parasite combination. In spite of evidence of strong immune responses to all of the antigens in the cocktail,
vaccination with this combination of tick and parasite antigens did not appear to effect tick feeding success or
reduce transmission of T. parva.
Conclusion: The results of this study highlight the importance of early evaluation of anti-tick vaccine candidates in
biologically relevant challenge systems using the natural tick-host-parasite combination.
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Background
During tick feeding saliva proteins are secreted into the
feeding lesion in the skin of the vertebrate host. The saliva
of ticks has been shown to contain an array of biologically
active proteins with functions essential to feeding success
[1]. Among other things these include: (i) immunosup-
pressive components to prevent the host from rejecting
the tick and to suppress inflammation and irritation thus
reducing the chances of being groomed off; (ii) anticoagu-
lants and vasodilators to prevent blood clotting and keep
blood flowing; (iii) cement cone proteins to ensure attach-
ment to the host [2]. Repeated host exposure to tick feed-
ing has been shown to result in the development of
resistance against future infestations, most likely through
development of an adaptive immune response targeting
the saliva proteins [1–5]. This natural ability to develop
resistance to ticks forms the conceptual basis for develop-
ment of vaccines targeting tick feeding. Vaccinating with
tick saliva antigens can induce production of antibodies
that bind to and interfere with the function of the proteins
in tick saliva. If particular saliva proteins are essential and
have non-redundant functions, antibody binding should
abrogate their functions and reduce feeding success. If
antibodies to the particular saliva protein can block the
function of essential saliva proteins they can make the
feeding site a hostile environment for the tick and for the
pathogens in such a way that effective feeding and trans-
mission cannot take place. In addition, interference with
saliva components that inhibit itch and inflammation and
aid attachment may make the feeding ticks more subject
to being groomed off. Either of these mechanisms may re-
sult in tick mortality, reduction in tick feeding success
and/or reduced reproductive capacity, which may in turn
reduce transmission of tick-borne disease [6–9].
Although a number of specific tick antigens have been
proposed as potential transmission blocking vaccine can-
didates, no commercially available anti-tick feeding vac-
cine has been developed. Instead, tick vaccine studies have
focused on concealed targets in the tick gut which induce
mortality by damaging the gut and interfering with blood
meal digestion. Bm86 is a tick gut protein that has been
used as a commercial vaccine. These vaccines have been
commercially available (Tick-Guard, Gavac), but their effi-
cacy has been spotty and unpredictable and they have seen
limited use [10, 11]. The value of anti-tick vaccine candi-
dates like Bm86 can be established by examining tick feed-
ing success and survival but it has been particularly
difficult to establish the value of these antigens in com-
parison to other candidates because there is no standard-
ized protocol for evaluation of anti-tick vaccine efficacy.
Apart from the obvious differences in antigen preparation,
formulation and administration there are also differences
in tick and host species and type of challenge used in vac-
cine trials. Antigens which prove effective in non-natural
host models may behave very differently when evaluated
using natural tick-host combinations. Vector-borne host-
tick-pathogen relationships co-evolved over long periods
of time and antigens proving effective against one species
of tick may not prove effective against another.
East Coast fever (ECF) caused by the protozoan parasite
Theileria parva is considered the most devastating tick-
borne disease of cattle in sub-Saharan Africa [12–14].
Theileria parva is transmitted by the three-host tick Rhi-
picephalus appendiculatus. Infection with this parasite re-
sults in high rates of mortality and morbidity [12–14]. The
development of a sustainable control method for ECF is
critical for increased livestock production in affected areas
[13]. Using the ECF as a model system, we attempted to
interrupt successful tick feeding by targeting different
aspects of tick physiology through vaccination with tick
antigens. The antigens were chosen based on previous
published work that either demonstrated a measurable
anti-tick effect in other host/tick species or showed poten-
tial as an anti-tick antigen based on a demonstrated affect
that may interfere with tick feeding. Antigens chosen in-
cluded two female and one male-derived R. appendicula-
tus histamine binding protein, the cement cone protein
TRP64, subolesin and p67C. Tick histamine binding pro-
tein is thought to sequester host histamine in the feeding
lesion, neutralizing host inflammation and immune re-
sponses, reducing the likelihood of rejection from the
feeding site and manual removal by grooming [15]. TRP64
was identified as a R. appendiculatus cement cone protein,
antibodies to which bind to both epitopes present in the
saliva as well as within the midgut [16]. The cement cone
is essential to anchor the tick to the host skin [1, 2]. Subo-
lesin has been identified as an intracellular regulatory pro-
tein with a role in signal transduction and vaccination
against this protein has shown anti-tick effects on other
tick species [11]. In addition to tick antigens, T. parva
sporozoite surface antigen p67C, has shown variable effi-
cacy in previous studies and it was included here to see if
it could act in a cumulative manner with the other anti-
gens to reduce transmission efficiency by interfering with
parasite entry into bovine host cells [17–19]. Although
each of these proteins alone may have an effect on feeding
success and transmission, we hypothesized that the com-
bination of several different antigens that may interfere
with saliva function and reduce transmission efficiency
through an incremental effect. For each of the candidate
anti-tick components, this is the first time they have been
tested in the natural host-tick-parasite model.
Methods
Vaccine antigen expression and purification
Antigens selected for the multivalent cocktail included
three R. appendiculatus histamine binding proteins [male
(HBPM, AAC63108.1), female-one (HBPF1, AAC63106.1)
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and female-two variants (HBPF2, AAC63107.1)] [15], two
different R. appendiculatus cement cone protein antigens
[TRP64 [full length (TRPFL, AF469170.1) and TRP trun-
cated variants (TRP18-89, amino acids 18-89)] [16], the R.
appendiculatus subolesin homologue (4D8, ABA62331.1)
and T. parva sporozoite antigen p67C [19]. Using the above
accession numbers, nucleotide sequences for each antigen
were retrieved from GenBank (http://www.ncbi.nlm.nih.-
gov/genbank/) and submitted to GenScript Corp. (New
Jersey, USA) for expression and purification. Antigens were
expressed in E. coli with either 6× His or TF tags and puri-
fied by affinity chromatography. Subolesin was expressed
with a GST tag, which was removed prior to vaccination of
cattle. The p67 C-terminal (p67C) antigen was cloned in
pQE30 and expressed in E. coli as outlined in Bishop et al.
[19]. Due to the small size of p67C, 80 amino acids
(≈10 kDa), size exclusion chromatography was used for
purification. Antigens were quantified using the Bradford
protein assay with BSA as a standard. All antigens were de-
termined to have a purity of 75 % or greater by SDS PAGE
and Coomassie blue staining (Fig. 1).
Vaccination of cattle with the multivalent cocktail
Thirty Bos tarus (either Friesian or Friesian/Ayeshire cross)
calves, 3 months of age, were randomized into two groups,
vaccinated (n = 20) and control (n = 10). Calves were raised
and maintained under strict tick-free condition and sero-
logically tested prior to use to confirm they were free of
tick-borne infections (babesiosis, theileriosis and anaplas-
mosis). The seven antigens were separated into two differ-
ent pools of inocula for vaccination to reduce the potential
for antigenic competition between vaccine components.
The first pool contained subolesin, HBPF2, TRP18-89 and
p67C and was administered subcutaneously over the left
shoulder. The second pool contained HBPM, HBPF1,
TRPFL and was administered subcutaneously over the right
shoulder. Inocula contained 50 μg of each antigen with the
final volume adjusted to 1 ml with phosphate buffered sa-
line (PBS) pH 7.4. Preparations were emulsified in an
equivalent 1 ml volume of Montanide ISA 50 V adjuvant
(Seppic, Paris, France) mixed according to the manufac-
turer’s instructions. Each animal received three inoculations
separated by four-week intervals (days 0, 28 and 56) for a
total of 150 μg of each antigen. Control preparations con-
sisted of 1 ml of PBS emulsified in 1 ml of Montanide ISA
50 V adjuvant. Control preparations were administered
subcutaneously over the left and right pre-scapular region
in the same way as the vaccination group. Serum samples
were collected from the jugular vein before the first vaccin-
ation and at two-week intervals thereafter until the end of
the study. Serum was stored at -20 °C until tested by ELISA
for reactivity against each individual antigen.
Monitoring humoral immune response to vaccination by
indirect ELISA
Humoral immune responses directed against each antigen
were monitored for each animal. Ninety six-well plates
(Polysorp, Nunc) were coated with 0.5 μg recombinant pro-
tein per well and incubated for one hour at 37 °C. All wash-
ing steps were carried out using Phosphate Buffered Saline
(10 mM PO4
3−, 137 mMNaCl and 2.7 mM KCl) containing
0.5 % (v/v) Tween 20 (PBST). Plates were washed three
times in an automated plate washer for each wash step.
Plates were blocked with 1 % casein in PBST for 30 min at
37 °C. Serum was applied at an initial concentration of
1:500 followed by 1:2 dilutions and incubated for one hour
at 37 °C. After washing, anti-bovine IgG, whole molecule,
peroxidase conjugate (Sigma, St. Louis, USA) was added at
a dilution of 1:10,000 in PBST and incubated for one hour
at 37 °C. Plates were washed and given a final rinse in PBS.
Plates were developed using SIGMAFAST OPD (Sigma, St.
Louis, USA) following instructions and signals were evalu-
ated at optical density (OD) 450 nm in a plate reader. Mean
readings (with standard error) were calculated for each time
point by grouping control and vaccinated animals. End-
point titres were determined as the last serum dilution
where the OD of test sera was ≥ 2 OD of negative control
bovine serum donor. Time points evaluated were before
Fig. 1 Coomassie blue stained gel showing SDS-PAGE analysis of the purified recombinant antigens incorporated into the multivalent vaccine.
M1, Protein Ladder; Lane 1, Histamine binding protein (male variant); Lane 2, Histamine binding protein (female variant 1); Lane 3, Histamine binding
protein (female variant 2); Lane 4, TRP64 (truncated); Lane 5, TRP64 full length; Lane 6, Subolesin; Lane M2, Protein Ladder; Lane 7, p67C
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vaccination and two weeks after each inoculation (days 0,
14, 42 and 70).
Evaluation of the effect of vaccination on tick feeding and
transmission of T. parva
Two different tick strains were used in this study. The R.
appendiculatus Muguga laboratory tick line [20] was
used to assess the effect of vaccination on tick feeding
success. The Muguga ‘low-line’ tick colony was used to
transmit T. parva parasites to cattle to assess the effect
of vaccination on transmission. The ‘low-line’ colony
was originally developed and has been maintained at the
International Livestock Research Institute (ILRI) Tick
Unit since 1994; this colony was selected from the
Muguga laboratory tick line by cross-breeding siblings
with reduced susceptibility to T. parva infection [21].
Normal uninfected Muguga colony ticks were routinely
reared on rabbits and cattle, and maintained in Bio-
logical Oxygen Demand (BOD) incubators at 28 ± 1 °C
when not feeding on hosts. Infected ‘low-line’ ticks for
the transmission component of the study were produced
as described in Odongo et al. [22]; briefly, ticks were in-
fected with T. parva by feeding as nymphs on an in-
fected calf and after molting to adults were maintained
until used for transmission in BOD incubators at 24 ±
1 °C, 80 % relative humidity.
Evaluation of the effect of anti-tick vaccination on tick
feeding and tick reproductive capacity
Two weeks following the final vaccination, normal col-
ony ticks were applied to each calf in two separate tick-
feeding bags attached with adhesive to the skin of each
calf. One bag was attached to the back of the calf and
contained 200 nymphs. Anti-tick effects on nymphs
were measured as engorgement weight (average for 100
ticks) and the proportion of nymphs successfully molting
to adult. A second feeding bag was attached to the base
of the left ear and contained 50 adult females and 50
adult males. Assessment of the effect of vaccination on
female feeding success included: mortality rate (number
replete out of 50 applied); average engorgement weight
of each female and egg laying/hatching capacity. Male
ticks were only applied to stimulate female feeding and
were not used as part of the anti-tick assessment.
Evaluation of the effect of vaccination on transmission of
T. parva
The vaccine cocktail was evaluated by exposing cattle to
T. parva infected ‘low-line’ ticks. The T. parva infection
rate in the female tick population used for challenge was
calculated to be 20 % with the average of 5.8 infected
acini per infected tick based on stained salivary gland
smears [23]. Thirty T. parva infected female ‘low-line’
ticks were placed together with thirty uninfected male
ticks in an ear bag attached to the base of the right ear
of each calf. Uninfected male ticks were added only to
stimulate the feeding of female ticks and did not con-
tribute to parasite burden. Female ticks were allowed to
feed till repletion after which engorgement weight and
egg laying capacity were measured. Transmission was
measured as the ability of adult females to feed success-
fully and transmit T. parva to calves. Rectal temperature
was recorded daily after tick application, pyrexia was de-
fined as a rectal temperature above 39.5 °C. Transmis-
sion of T. parva parasites and the establishment of
infection was evaluated using a combination of: (i) mi-
croscopy; (ii) PCR and (iii) serology. Transmission was
deemed to have occurred if antibodies to T. parva could
be detected along with PCR detection and/or micro-
scopic identification of parasites. In the event of acute
disease calves were treated as required with short- or
long-acting oxytetracycline (Copermycin or Butalex®,
respectively).
Microscopy
Lymph node biopsies were taken daily from day ten after
tick challenge in the local lymph node draining the site
of infection (right parotid lymph node), and from day 15
in the contralateral left pre-scapular lymph node. Peri-
oheral blood was collected from the ear vein. Lymph
node aspiration smears and blood smears were stained
with Geimsa and examined for the detection of schiz-
onts and piroplasms respectively [24].
PCR
Blood samples for PCR analysis taken from each calf
two weeks after infection. DNA was extracted using the
DNeasy Blood and Tissue kit (Qiagen, Hilden, Germany)
according to instructions. The p104 gene PCR parame-
ters and the primers used in the primary PCR were as
described previously [25, 26]. All reactions were per-
formed in 15 μl volumes using 5 μl of DNA extracted
from blood for the primary reaction or 5 μl of the pri-
mary PCR reaction for the nested PCR reaction with
0.25 units of Taq DNA polymerase, (Promega, Madison,
USA), 1× PCR buffer (Promega), 200 mM of each dNTP
(Promega) and 25 ng of primers and 1.5 mM of MgCl2.
The final PCR products were visualized by Ethidium
bromide staining and UV trans-illumination.
Serology
Antibodies against the T. parva PIM antigen were de-
tected using the PIM-ELISA developed at ILRI, as previ-
ously described [27]. Serum samples used for detection
were taken 12 weeks after tick application (in cases
where animals died or were euthanized, the last sample
before death was used for serology).
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Results
Two animals were removed from the analysis of the
transmission experiment due to concurrent lungworm
infections which could potentially exacerbated clinical
signs of East Coast fever. However, ticks collected from
these animals were still included in the evaluation of
anti-tick effects.
Antibody titres
Antibody titres against each antigen could be detected in
all vaccinated animals (Fig. 2; Additional file 1: Table S1).
There was a large difference between the antigenicity of
the truncated and full-length versions of TRP. The average
titre for the full length version of TRP64 was 1:10,700
compared to 1:33,000 for the truncated TRP. There were
roughly equal responses to the histamine binding protein
variants, between 1:30,000 and 1:38,800, with marginally
higher titres developed to the male variant. High antibody
titres were generated against subolesin (average endpoint
titres of 1:40,600) but lower titres were observed against
p67C with average endpoint titres of only 1:8,500.
Anti-tick effect of vaccination
Despite demonstrable antibody titres to each component
of the anti-tick vaccine cocktail, no significant anti-tick
effects were observed in the normal Muguga colony
ticks (Table 1, Additional file 1: Table S2). Nymphal ticks
fed equally well in both groups with the average weight
of 100 pooled nymphs being 1.2 g for cattle in both the
vaccinated group (n = 20) and control group (n = 10).
Nymph molting was not inhibited in the vaccine group
with 98.1 % successfully compared to 97.9 % in the con-
trol group (Mann-Whitney U = 100; n1 = 20, n2 = 10; P =
0.351; two-tailed). The multivalent cocktail had no effect
on adult female survival with an average of 47 of 50 ticks
from the vaccinated group and 46 of 50 collected in the
control group (Mann-Whitney U = 79; n1 = 20, n2 = 10;
P = 0.221; two-tailed). Female ticks from the vaccinated
group laid on average 304 mg of eggs compared to ticks
in the control group females which laid 246 mg each
(Mann-Whitney U = 56.5; n1 = 20, n2 = 10; P = 0.056;
two-tailed) There was little variation in tick feeding suc-
cess within the vaccinated group ticks and no correlation
between tick biological parameters and antibody titre to
specific antigens could be established.
The effect of vaccination was more pronounced in the
infected Muguga ‘low-line’ ticks. Ticks fed less effectively
on vaccinated hosts in almost all parameters measured
(Table 2; Additional file 1: Table S3). Ticks collected
from vaccinated cattle laid 67 ± 40 mg of eggs per tick
compared to control ticks (83 ± 34 mg) (Mann-Whitney
U = 75.5; n1 = 20, n2 = 10, P = 0.383; two-tailed). An
Fig. 2 Development of antibody titres against vaccine antigens pre- and post-vaccination. Time points evaluated included pre-vaccination (day
0), two weeks after first inoculation (week 2), two weeks after second inoculation (week 6) and two weeks after third inoculation (week 10). a
TRP64. b Subolesin. c p67C. d Histamine binding protein
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average of 15 replete females were recovered from vacci-
nated cattle (14.9 ± 7.6) compared to 18 from control
cattle (17.8 ± 7.6) (Mann-Whitney U = 81.5; n1 = 20, n2 =
10; P = 0.550; two-tailed). Female ticks collected from
vaccinated cattle weighed 238 ± 79.0 mg compared to
ticks collected from control animals (275 ± 30.0 mg)
(Mann-Whitney U = 78.5, n1 = 20, n2 = 10; P = 0.462;
two-tailed). Overall, ‘low-line’ ticks may have been more
sensitive to vaccine-induced antibodies than normal col-
ony ticks. In general, the ‘low-line’ ticks did not feed as
well as normal colony ticks and for the tick parameters
measured, there was more variation between individual
animals for ‘low-line’ ticks than normal colony ticks.
This could not be correlated with antibody titre and
most likely due to other factors such as T. parva infec-
tion level or ‘low-line’ strain biology [22].
Evaluation of the effect of vaccination on transmission of
T. parva
The T. parva infection rate in the female tick population
used for challenge was calculated to be 20 % with the
average of 5.8 infected acini per infected tick. Based on
an infection rate of 20 % in the tick population we would
estimate that each animal was challenged by at least ≈ 6
ticks with infections discernable by smear analysis. De-
tection of T. parva in cattle after exposure to infected
ticks was measured using three methods: microscopy,
serology and PCR. Transmission was deemed to have
occurred if antibodies to T. parva antigen PIM could be
detected in addition to either (or both) PCR detection of
parasite DNA or microscopic presence of parasites in
blood/lymph node smears. Transmission of T. parva
from infected ticks was confirmed in each animal indi-
cating that vaccine-induced transmission blocking did
not occur (Table 3).
Kaplan Meier plots (Fig. 3) show that while transmis-
sion blocking did not occur; slightly milder disease clin-
ical signs were observed in the vaccinated group
although this difference was not statistically significant.
No clinical signs of ECF disease were detected in two
animals in the vaccinated group (BF003 and BF030,
Additional file 1: Table S4). Both cattle showed no visible
parasitemia (either shizonts or piroplasms) or pyrexia re-
sponse while all animals in the control group showed at
least one clinical sign of infection. Although no correl-
ation between anti-p67 titre and severity of disease was
observed, calf BF003 and BF030 did have anti p67 end-
point titres of 1:12,000 and 1:16,000 respectively, both
above the group average of 1:8,500. Fewer animals in the
vaccinated group 83 % (15 out of 18) compared to 90 %
(9 out of 10) control animals developed pyrexia (Table 3).
During East Coast fever infections, parasites infecting
lymphocytes (schizonts) are disseminated through the
body of the infected animal. Presence of schizont stage
parasites in the lymph node draining the site of infection
indicates establishment of infection. Schizonts also were
detected in 90 % (9 out of 10) control animals and in
72 % (13 of 18) vaccinated animals (Table 3).
Discussion
It was hypothesized that the anti-tick feeding and anti-
parasite effects of the components of this multivalent
cocktail would act cumulatively, leading to a reduction
in tick feeding and thereby T. parva transmission. Tick
saliva components contained in the vaccine aimed to
reduce or inhibit tick feeding. With feeding reduced, ex-
posure of the host to tick-borne pathogens would in
turn also be reduced. Through the action of the parasite
Table 1 Evaluation of the effect of multivalent anti-tick vaccine
on the biological fitness of normal Rhipicephalus appendiculatus
adult ticks and nymphs from the Muguga colony
Vaccinated
cattle hosts
(n = 20)a
Control cattle
hosts
(n = 10)a
U-valueb P-valueb
Nymphs
Average weight of
100 nymphs
1.2 ± 0.0 1.2 ± 0.0 100.0 < 0.999
Nymphs molting
successfully of 100c
98.1 ± 0.4 97.9 ± 0.4 79.0 0.351
Adults
Number of
engorged females
recovered from 50
applied
46.5 ± 1.3 45.9 ± 1.0 71.5 0.208
Average adult
female replete
weight (mg)
528.0 ± 12.0 548.0 ± 9.0 69.5 0.187
Total egg weight
laid (g)
13.4 ± 0.6 11.5 ± 0.9 64.0 0.117
Average egg
weight/tick (mg)
304 ± 17 246 ± 15 56.5 0.056
aValues represent the mean ± standard error of the mean (SEM)
bMann-Whitney test: vaccinated vs control group
cPercentage of nymph ticks successfully molting to the adult stage in a
random population of 100 individuals collected for monitoring
Table 2 Comparison on the feeding efficacy of Theileria parva-
infected Rhipicephalus appendiculatus Muguga ‘low-line’ ticks
Vaccinateda Controla U-valueb P-valueb
Number of engorged
females recovered from
30 applied
14.9 ± 7.6 17.8 ± 7.6 81.5 0.550
Average adult female
replete weight (mg)
238 ± 79.0 275 ± 30.0 78.5 0.462
Total egg weight laid (g) 1 ± 0.6 1.4 ± 0.7 59.5 0.106
Average egg weight/tick
(mg)
67 ± 40 83 ± 34 75.5 0.383
aValues represent the mean ± standard error of the mean (SEM)
bMann-Whitney test: vaccinated vs control group
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component, anti-parasite antibodies would target and
serologically neutralize any parasites entering the bovine
host inhibiting infection of lymphocytes thereby block
parasite transmission to the host [17–19]. The anti-tick
effect of the vaccine cocktail was evaluated in both
nymph and adult female R. appendiculatus ticks. Thei-
leria parva infection rates are highest in adult females
they are considered the most important stage for acute
disease transmission. Nymphal ticks have lower infection
levels and are considered important for the transmission
of sub clinical disease and as a parasite acquisition stage
for adult ticks [28]. The effect of the vaccine focused on
the ability of nymph and adult female ticks to success-
fully feed and for adult females to transmit T. parva.
As no significant anti-tick effect was observed it can be
assumed that vaccination had no impact on tick feeding
and host exposure to the parasite was not reduced through
vaccination. All tick antigens selected for this study had a
published history of being effective anti-tick vaccine candi-
dates or showed a potential role in successful feeding in
other tick-host models. Tick subolesin was first identified
in Ixodes scapularus and its efficacy as an anti-tick vaccine
has been evaluated in a number of tick species using a var-
iety of approaches. In I. scapularis, subolesin has a
Table 3 Development of East Coast fever symptoms in cattle vaccinated with the multivalent antigen cocktail after exposure to
Theileria parva-infected ‘low-line’ ticks
Vaccinated cattle (n = 18) Control cattle (n = 10) P-value
Pyrexiaa,b Number of animals where symptom
observed (%)
15 (83 %) 9 (90 %) < 0.999d
Day of first onset 10.3 (1.2) 11.1 (1.8) 0.801e
Duration 5.8 (0.9) 5. 6 (1.4) 0.803e
Regional lymph node
parasitosisa
Number of animals where symptom
observed (%)
13 (72 %) 9 (90 %) 0.375d
Day of first onset 13.5 (0.6) 14.0 (1.1) 0.774e
Duration 4.2 (0.7) 3.7 (0.9) 0.547e
Contra-lateral lymph node
parasitosisa
Number of animals developing
symptom (%)
8 (44 %) 6 (60 %) 0.695d
Day of first onset 16.1 (0.5) 17.2 (0.6) 0.211e
Duration 3 (0.8) 2.5 (1.7) 0.825e
Piroplasma Number of animals where symptom
observed (%)
5 (28 %) 4 (40 %) 0.678d
Day of first onset 17.6 (0.6) 17.0 (0.4) 0.722e
Duration 3 (0.6) 3 (0.7) < 0.999e
Nested p104 PCR detection of parasites 17 (94 %) 9 (90 %) < 0.999d
PIM antibodies Number of animals where antibodies
detected (%)
18 (100 %) 10 (100 %) < 0.999d
Average PP valuec 44.7 ± 16.1 53.4 ± 22.8 0.249e
aValues are displayed as the average day of first detection (SEM). Where symptoms were not observed in an animal, no values are reflected
bPyrexia was defined as rectal temperature exceeding 39.5 °C
cThe average Percentage Positive (PP) value calculated as the (OD of test sample/OD of strong positive) × 100
dFischer’s exact test
eMann-Whitney test
Fig. 3 Kaplan-Meier curves for time of first onset of ECF clinical signs in vaccinated and control cattle, a showing development of pyrexia
(temperature above 39.5 °C) and b showing the identification of schizont stage parasites in the lymph node draining the site of infection
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proposed role as an intracellular regulatory protein involved
in signal transduction [11]. Vaccination with subolesin has
been shown to protect against I. scapularis infestations,
resulting in reduced tick survival, feeding and reproduction
[29–43]. Interference with subolesin through either vaccin-
ation or RNAi reduced tick infection rates with pathogens
Anaplasma marginale, Anaplasma phagocytophilum and
Babesia bigemina [36–38]. The effect of vaccination with
subolesin on R. appendiculatus has not been investigated
but showed promising results for the control of cattle tick
species R. microplus and R. annulatus [37–39]. Both
subolesin-sensitive species R. microplus and R. annulatus
are one-host tick species, feeding on a single host from lar-
vae till engorged adults. This is in contrast to R. appendicu-
latus, a three-host tick which feeds on a separate host at
each stage. This stark difference in feeding behavior pro-
vides one-host tick species a much longer exposure period
for antibodies targeting tick antigens to bind to and cause
damage compared to a three-host tick species. Even where
subolesin has been shown effective as a tick control antigen,
tick species-specific vaccine effects vary. The anti-tick effect
of subolesin vaccination on R. microplus was predominantly
reduction of tick infestation with a small reduction in egg
fertility [35, 42, 43]. In contrast, R. annulatus primarily
showed reduced oviposition and egg fertility with lower re-
ductions in infestations [42]. From the current study we
have concluded that vaccination with subolesin is unlikely
to be useful as a control method for R. appendiculatus.
TRP64 (64TRP) was identified as a R. appendiculatus
cement cone protein, antibodies to which bind to both
epitopes present in the saliva as well as within the midgut
[16]. Sera raised against various truncated versions of
TRP64 cross reacted with tissue extracts from Rhipicepha-
lus sanguineus, Ixodes ricinus, Amblyomma variegatum
and R. microplus [44]. Anti-tick effects against non-target
tick species R. sanguineus, I. ricinus, A. variegatum and R.
microplus were observed after 64TRP vaccination of
guinea pigs [44, 45]. Rhipicephalus appendicualus ticks
fed on TRP64 vaccinated guinea pigs showed increased
mortality, decreased mean engorgement weight and de-
creased egg-laying mass [16]. Vaccination of rabbits with
TRP64 did not produce a measurable anti-tick effect on R.
appendiculatus [46]. Vaccination of mice with 64TRP was
shown to inhibit tick feeding as well as reduce levels of
transmission of tick-borne encephalitis virus by I. ricinus
making it a transmission blocking vaccine candidate [47].
None of the anti-tick effects demonstrated for 64TRP in
small-animal models could be replicated in our experi-
ment using the natural host-vector system despite the in-
duction of high antibody titres to both TRP64 variants in
cattle.
Histamine binding proteins contained within the tick
saliva are thought to play a role in controlling the inflam-
mation and itch-responses by sequestering histamine at
the feeding site competing with host histamine receptors
[15]. Although not previously evaluated as an anti-tick
vaccine candidate, R. appendiculatus histamine binding
protein was able to prevent murine allergic asthma [48].
By inhibiting tick histamine binding protein, the feeding
site may become a hostile environment leading to a reduc-
tion in tick feeding. In this study, cattle were restrained by
the head in stalls during tick feeding. This restraint would
have made them unable to groom, even if the itch re-
sponse had been greater in the vaccinated group. The
components of tick saliva are highly redundant [1] and
even if a component is completely neutralized, it is pos-
sible that other molecules performing the same or similar
functions are present. Although saliva antigens are attract-
ive targets for anti-tick vaccination, this approach may be
unlikely to succeed due to the complexity of tick saliva.
The lack of protection observed after vaccination may
be as a result of a number of factors. The observed dif-
ferences in anti-tick effects between the antigens used
here and those reported in other host-vector systems
may be partly related to specific tick antigen recognition
patterns by the host species. Tick components detected
by the experimental non-native host species may not be
immunogenic in the natural host-tick system [1]. The
varying epitopes recognized by different host species
after vaccination may in part account for the differences
in anti-tick effects. This phenomenon is well illustrated
when R. sanguineus ticks, which naturally feed on dogs,
are fed on guinea pigs. In guinea pigs, resistance to R.
sanguineus results after a low number of tick bites, char-
acterized by high tick mortality, reduced engorgement
weights and reproductive capacity likely due to their nat-
ural resistance to ticks. In stark contrast, repeated ex-
posure of dogs to R. sanguineus results in an immediate
inflammatory response in the skin with a delayed hyper-
sensitivity response and little resistance [49–51].
Although inoculation of antigens was split over two in-
jection sites to avoid antigenic competition, it is possible
that competition still occurred. Studies have shown that
antigenic competition occurs when multiple antigens are
simultaneously inoculated even when using separate in-
jection sites [52]. Lower antibody titres to each antigen
are developed and overall vaccine efficacy is reduced
[52–54]. As five of the seven tick antigens are variants of
each other (male and female histamine binding proteins;
full and truncated versions of TRP64) competition likely
still have occurred even with separate inoculation sites.
As a result, the actual individual anti-tick effects of each
of these antigens in the R. appendiculatus-cattle model
still remains unknown. Due to the redundant nature of
tick saliva, balancing redundancy with antigenic compe-
tition will be important in future saliva based anti-tick
vaccine studies. In addition to antigenic competition, the
choice of adjuvant and protein expression system used
Olds et al. Parasites & Vectors  (2016) 9:484 Page 8 of 11
in this study would undoubtedly play a role in the ultim-
ate success of these antigens as tick control candidates.
As no anti-tick effect could be demonstrated with the
antigen cocktail, any transmission blocking would be due
to the action of the anti-parasite component of the vaccine.
The T. parva antigen p67 is expressed on the sporozoite
surface and is involved in parasite entry into bovine lym-
phocytes [18]. Results obtained from experimental trials
with p67 showed that vaccination could protect between 60
and 70 % of cattle from lethal sporozoite needle challenge
[18, 19, 55]. Under field-based tick challenge (determined
to be low to moderate in intensity), the vaccine failed to
achieve previously reported levels of protection. In three
geographically separate trial sites, two showed no significant
reduction of severe ECF. In the third site, a significant re-
duction of severe ECF by 30 % was observed [56]. Needle
challenge experiments run concurrently with field trials
showed a decrease in the incidents of severe ECF by ap-
proximately 50 % suggesting that protective efficacy varies
between natural tick challenge and artificial needle chal-
lenge [56]. Of all the antigens administered in this study,
antibody titres targeting p67 C were the lowest. An increase
in titres may be achieved through increasing the amount of
antigen used to vaccinate cattle (previous p67 vaccination
studies administered a total of 450 μg of antigen, compared
to 150 μg used in this study) or changing the vaccine for-
mulation. It is possible that antigenic competition with tick
antigens also contributed to the poor response to p67. Para-
sites were successfully transmitted to each calf confirmed
by anti-PIM antibodies, microscopy and/or PCR indicating
that parasite blocking was not successfully achieved. The
onset and severity of ECF disease clinical signs is related to
the number of parasites inoculated into the host. Cattle re-
ceiving higher numbers of sporozoites generally develop
clinical signs earlier with higher parasitemia than those
receiving lower doses [12, 57]. As the exact number of
sporozoites each animal received through tick feeding is
unknown, it is difficult to know if animal BF003 and BF030
did not develop disease clinical signs due to their higher
p67 antibody titres or a chance lower tick infection rate.
BF025 had the highest anti-p67 titre (1:32,000) and still
develop schizont parasitosis in both regional and contra-
lateral lymph nodes suggesting that the individual tick chal-
lenge received by each animal is an important factor in
disease severity in this study.
The only meaningful evaluation of this combination of
tick and parasite antigens had to employ natural feeding
of infected ticks to deliver infectious parasites. Although
the ‘low line’ used in this study was bred to have a low
susceptibility to infection this is compared to a labora-
tory line with high susceptibility to infection [21]. After
feeding on an acutely parasetimic host, infection rates in
the artificially selected ‘low-line’ are still higher than ani-
mals would likely be exposed to under field conditions.
Reported field infection rates in East Africa are generally
low with less than 5 % of the tick population infected
and infected ticks show low levels of infection, around 1
infected acini per tick [58–61]. The tick population used
in this study had a 20 % infection rate with individual
tick infections ranging from 1 and 24 infected acini per
tick. Furthermore, Odongo et al. [22] showed that nested
PCR was able to detect more infected ticks than micros-
copy, suggesting that the estimated challenge dose of 6
infected ticks in this study may be a considerable under-
estimate of the actual exposure in this experiment. In fu-
ture, the development of a tick challenge model more
representative of what animals would encounter under
natural field conditions is important. This should involve
feeding non-selected tick lines on persistently infected
cattle with lower parasitemia apposed to selected lines
fed on acutely parasitemic hosts. This will allow the pro-
duction of tick challenge material with a more uniform
infection rate reducing the sporozoite dose variation ex-
perienced by individual cattle. Such a challenge model
would make study results easier to interpret and allow
protective antibody titres to be identified.
It was interesting to note that the effect of vaccination
on tick feeding differed between the two tick strains
used in this study. In general, ticks from the Muguga
‘low-line’ are routinely smaller than Muguga normal
colony ticks and it is thought that less effective feeding
contributes to the lower T. parva infection rates in the
‘low-line’ [22]. Subolesin vaccination resulted in reduced
oviposition in R. annulatus [42] and it is possible that
antibodies targeting subolesin accounted for the reduced
egg laying capacity in the Muguga ‘low-line’ ticks. Why
it does not affect the normal colony in the same manner
is unknown, but the results highlight that anti-tick ef-
fects may vary between strains of the same tick species.
The implication of this being that anti-tick effects on
field tick populations may be vastly different to those
observed when using laboratory strains.
Conclusion
A combination tick-parasite multivalent vaccine was eval-
uated for its effect on R. appendiculatus feeding and T.
parva transmission. This is to our knowledge the first re-
port of the evaluation of these antigens in the biologically
relevant tick-host-pathogen system. Both, the anti-tick
and transmission blocking potential of this vaccine was
not significant enough to merit further pursuit of this spe-
cific antigen combination in the current formulation. Al-
though candidates were selected to act in a cumulative
manner, antigenic competition between antigens may have
reduced the efficacy of antigens. The effect of the individ-
ual antigens remains unknown and changes in vaccine for-
mulation may improve the anti-tick effect. Interestingly,
anti-tick vaccine effects varied between tick strains,
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suggesting differences between the Muguga ‘low-line’ and
normal colony despite originating from the same parent
stock. Together, the data from this study highlights the
importance of early evaluation of any proposed anti-tick
antigen in the natural host-tick system for a more accurate
representation of the likely effects.
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